The Radiation Oncology Institute (ROI) has named Christopher G. Slatore, MD, recipient of a $200,000 award, distributed over 2 years, for a project to examine the comparative value of radiation therapy and patient outcomes among patients with lung cancer. Dr. Slatore is Assistant Professor in the Division of Pulmonary and Critical Care Medicine at the Portland VA Medical Center in Portland, Oregon.
Overview of Study Goals
Dr. Slatore will conduct a prospective, longitudinal, quantitative, and qualitative study among patients with early-stage non–small cell lung cancer undergoing routine care to better understand patient-centered outcomes associated with the differing treatments (ie, surgical resection,
stereotactic body radiotherapy, external beam radiation, treatment deferral). In addition, he will evaluate patient-clinician communication to determine its influence on outcomes and decision-making.
“We are proud to confer this important award to Dr. Slatore; he is an exemplary leader in research focused on patient-centered care for non-small cell lung cancer, and we look forward to the results of this impressive and meaningful study,” said ROI President Theodore Lawrence, MD, PhD, FASTRO. “ROI is committed to supporting research that examines the comparative value of radiation therapy because it can improve cancer care and has the potential to generate the evidence needed to improve cancer outcomes, while slowing the growth of health-care spending,” Dr. Lawrence said.
